Ketorolac Tromethamine Ophthalmic Information

What's inside Ketorolac Tromethamine Ophthalmic

Ketorolac Tromethamine Ophthalmic in the News

Young woman presents with decreasing vision - OSN SuperSite (subscription)
Our patient was also initially started on topical prednisolone and Acular (ketorolac tromethamine 0.5%, Allergan) eye drops, each four times per day. ...
Tue Mar 04 14:03:20 -0500 2008

Akorn Reports Third Quarter 2007 Financial Results - Genetic Engineering News (press release)
... Ketorolac Tromethamine Injection USP, 15 mg/mL and 30 mg/mL. -- July 27, 2007: Akorn announced FDA approval of Ketotifen Fumarate Ophthalmic Solution, ...
Thu Nov 01 16:40:18 -0400 2007

Allergan Reports Second Quarter Operating Results - PharmaLive.com (press release)
... (ketorolac tromethamine ophthalmic solution) 0.5% and enjoining the Defendants from manufacturing or selling their product before US Patent No. ...
Wed Aug 01 06:14:50 -0400 2007

Ketorolac Tromethamine Ophthalmic Chemical Information

ketorolac tromethamine - The tromethamine salt form of ketorolac, a synthetic pyrrolizine carboxylic acid derivative with anti-inflammatory, analgesic and antipyretic properties. Ketorolac, a non-selective inhibitor of the cyclo-oxygenase (COX) enzyme, prevents the synthesis of prostaglandins and thromboxanes from arachidonic acid. COX enzymes exist in two isoforms; inhibition of the COX-2 enzyme produces the anti-inflammatory and analgesic whereas, inhibition of the COX-1 enzyme is associated with gastrointestinal side effects, nephrotoxicity and platelet de-aggregatory effects.